MTOR and neoplasm: This study was aimed at uncovering the anti-tumor mechanisms of YYN-37 across different cellular contexts, thereby offering foundational insights and innovative perspectives for the development of anti-cancer therapeutics targeting the PI3K/mTOR pathway.